![ECOG-ACRIN logo[19516]275×75](https://blog-ecog-acrin.org/wp-content/uploads/2021/03/ECOG-ACRIN-logo19516275x75.png)
September 14, 2020
Welcome to the News From ECOG-ACRIN blog; COVID-19 month six reflections; clinical trial enrollment continues to improve; EA Cancer Research Advocates Committee adds five new members
September 14, 2020
This phase II trial by EA's Cancer Control and Survivorship Committee is comparing two promising pneumonitis treatments for patients receiving PD-1/PD-L1 therapy
September 14, 2020
A second interim analysis of this international adjuvant study for HR+, HER2- early breast cancer demonstrates that there is little chance of palbociclib reducing the risk of recurrence
September 14, 2020
Up to eight young investigators will present their work at the annual Young Investigator Symposium, taking place during the Virtual Fall 2020 Group Meeting
September 14, 2020
This is the only study that is currently designed to test the ability to improve long-term outcomes by refining early-setting triple-negative breast cancer chemotherapy without exposing ALL patients to more toxicity preoperatively
July 29, 2020
In the fifth month of restrictions due to COVID-19, member institutions pivot back to focus on general health care; clinical trial enrollments begin to rise back up to pre-pandemic levels; Fall 2020 Group Meeting to be virtual; EA holds first meeting of planned move to an anti-racist agenda
July 29, 2020
In July, the field of radiology lost one its most influential leaders
July 29, 2020
Currently, there is no treatment standard for metastatic pancreatic cancer in people aged 65 years and older
July 29, 2020
Learn more about a less intense treatment that preserves throat function and spares unnecessary toxicities
July 29, 2020
A special webcast in June focused on moving to an explicit anti-racist ECOG-ACRIN agenda
July 29, 2020
A Standing Main Member of ECOG-ACRIN since 1996
July 29, 2020
